Indications and uses
Helps prevent sunburn. If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.
Helps prevent sunburn. If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.
Apply liberally 15 mtnutes before sun exposure. Reapply: - After 80 minutes of swimming or sweating - Immediately after towel drying - At least every 2 hours Children under 6 months: Ask a doctor Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other s...
DRUG FACTS
Titanium Dioxide 8%
Zinc Oxide 3.8%
Sunscreen
Sunscreen
Helps prevent sunburn. If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
For external use only.
Do not use on damaged or broken skin.
Stop use and ask a doctor if rash occurs.
When using this product, keep out of eyes. Rinse with water to remove.
Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Alumina, Cyclohexasiloxane, Cyclopentasiloxane, Dimethicone, Dimethicone Crosspolymer, Dimethicone/Vinyl Dimethicone Crosspolymer, Dimethiconol, Iron Oxide (CI 77491), Lauryl PEG/PPG 18/18 Methicone, Methicone, PEG-10 Dimethicone
Principal Display Panel – Carton Label
DERMATOLOGIST RECOMMENDED
CōTZ®
FACE
The Healthier Sunscreen
Silky Soft
Blends Translucent
Sheer Matte Finish
Balanced Mineral Complex™ Helps Prevent
Heat Build-Up in Skin, which can
Damage the Dermis
100% Free of:
Preservatives, Chemical Sunscreens, Oils
Natural Skin Tone
Water Resistant
(80 minutes)
Broad
Spectrum
SPF 40
Net Wt. 1.5 oz/ 42.5 g

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 58892-356-45 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e63f-cd31-e053-dbdaa90ab51a | dd68eba8-8d90-487e-a659-327bc3b5bc1a |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58892-356-45 | Cotz Face (Natural Skin Tone) SPF 40 Sunscreen | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 58892-356-45 | Cotz Face (Natural Skin Tone) SPF 40 Sunscreen | 42.5 g in 1 TUBE | CREAM | 42.5 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| Titanium Dioxide | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| Aluminum Oxide | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| Cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| Cyclomethicone 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| Dimethicone 20 | INACTIVE INGREDIENT | H8YMB5QY0D | 1 | |
| Dimethicone/Diene Dimethicone Crosspolymer | INACTIVE INGREDIENT | RSA9I561OK | 1 | |
| Dimethiconol (100000 cst) | INACTIVE INGREDIENT | OSA9UP217S | 1 | |
| Ferric Oxide Red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| Lauryl PEG/PPG-18/18 Methicone | INACTIVE INGREDIENT | ZJ5S27D9NX | 1 | |
| Methicone (20 cst) | INACTIVE INGREDIENT | 6777U11MKT | 1 | |
| PEG-10 Dimethicone (600 cst) | INACTIVE INGREDIENT | 8PR7V1SVM0 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58892-356 | 58892-356-45 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, CHEWABLE / ORAL | 2 mg | ||
| Dimethicone 20 | DIMETHICONE 20 | H8YMB5QY0D | CREAM / TOPICAL | 5 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CREAM / TOPICAL | NA | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | DROPS / ORAL | NA | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 3.6 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET / SUBLINGUAL | 1 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 0.15 mg | ||
| Cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE / ORAL | 5 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | LOTION / TOPICAL | NA | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET / BUCCAL | 0.4 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, EXTENDED RELEASE / ORAL | 5 mg | ||
| Cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | POWDER, FOR SUSPENSION / ORAL | 1 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, DELAYED RELEASE / ORAL | 14 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | SUSPENSION, EXTENDED RELEASE / ORAL | 2.7 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, FILM COATED / ORAL | 3 mg | ||
| Aluminum Oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, COATED / ORAL | 0.12 mg | ||
| Aluminum Oxide | ALUMINUM OXIDE | LMI26O6933 | SPONGE / TOPICAL | NA | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, DELAYED RELEASE / ORAL | 37 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, COATED PELLETS / ORAL | 2 mg | ||
| Cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | 260 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 307df76d-c5b5-4c22-9507-05fcc5bf6d15 | dd68eba8-8d90-487e-a659-327bc3b5bc1a | 2013-01-03 | Warnings | 307df76d-c5b5-4c22-9507-05fcc5bf6d15 dd68eba8-8d90-487e-a659-327bc3b5bc1a |
Adverse event summaries are temporarily unavailable. Other product information remains available.